Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
The Lancet. Rheumatology|November 15, 2021
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
The Lancet. Rheumatology|June 30, 2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELYMark D Russell, Andrea Schaffer, Zijing Yang, et al.
The Lancet. Rheumatology|July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
BMJ (Clinical Research Ed.)|January 21, 2026
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELYMark D Russell, Andrea Schaffer, Katie Bechman, et al.
Rheumatology (Oxford, England)|November 6, 2023
Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flaresMark D Russell, Louise Ameyaw-Kyeremeh, Flora Dell'Accio, et al.
British Journal of Clinical Pharmacology|April 8, 2024
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rateAndrew D Brown, Louis Fisher, Helen J Curtis, et al.
BMJ Open|October 6, 2020
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysisNick G Cunniffe, Simon J Gunter, Michael Brown, et al.
The British Journal of Dermatology|February 10, 2023
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional surveySophia Quirke-McFarlane, John Weinman, Emma S Cook, et al.
Nature Communications|December 15, 2020
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case reportMatthew S Buckland, James B Galloway, Caoimhe Nic Fhogartaigh, et al.
Pageof 8